Finance

Lists
Q4 2026 earnings • in 5 days
See details
ACN:NYSE
Accenture Plc
$176.11
-0.73%
(-1.30) 1D
$176.13
+0.01% (+0.020)
After hours
Closed: Sep 25, 4:00:07 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ACN...
Open
$177.12
High
$186.34
Low
$175.74
Mkt. cap
107.77B
Avg. vol.
5.13M
Volume
4.96M
Dividend
3.70%
Quarterly dividend
$1.63
Ex-dividend date
Jul 9, 2026
P/E ratio
14.07
52-wk high
$291.09
52-wk low
$118.15
EPS
$12.52
Beta
1.10
Shares outstanding
611.94M
No. of employees
799K
Open
$177.12
High
$186.34
Low
$175.74
Mkt. cap
107.77B
Avg. vol.
5.13M
Volume
4.96M
Dividend
3.70%
Quarterly dividend
$1.63
Ex-dividend date
Jul 9, 2026
P/E ratio
14.07
52-wk high
$291.09
52-wk low
$118.15
EPS
$12.52
Beta
1.10
Shares outstanding
611.94M
No. of employees
799K
News stories
From web sources and news partners
Profile
Accenture plc is an Irish domiciled technology consulting company headquartered in Dublin, Ireland, for tax purposes. Founded in 1989 in the United States, Accenture provides information technology and management consulting services across 120 countries globally. Wikipedia
About Accenture Plc
CEOJean-Marc Ollagnier | Julie Sweet
Employees799K
Founded1989
Headquarters-
SectorInformation technology consulting
Websiteaccenture.com
Analyst ratings
Based on 14 analysts giving stock ratings to ACN in the past 3 months
Hold
Buy
3
Hold
11
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for ACN in the last 3 months.
Highest
Current $176.11
$230.00 (+30.60%)
Average
$188.92 (+7.27%)
Lowest
$140.00 (-20.50%)
Analyst
Recommendation
Action
Price target
Projected
Date
Sachin Mittal
DBS
Hold
Maintained
$185.00
+5%
09/25/2026
Tien Tsin Huang
J.P. Morgan
Buy
Reiterated
$200.00
+13.6%
09/25/2026
Keith Bachman
BMO Capital
Hold
Maintained
$200.00
+13.6%
09/23/2026
Surinder Thind
Jefferies
Hold
Maintained
$190.00
+7.9%
09/22/2026
James Faucette
Morgan Stanley
Hold
Maintained
$175.00
-0.6%
09/21/2026
Terry Tillman
Truist Financial
Hold
Maintained
-
-
09/21/2026
Nate Svensson
Deutsche Bank
Hold
Maintained
$175.00
-0.6%
09/18/2026
Jonathan Lee CFA
Guggenheim
Hold
Downgraded
-
-
09/20/2026
Bryan Bergin
TD Cowen
Hold
Maintained
$173.00
-1.8%
09/15/2026
Jason Kupferberg
Wells Fargo
Hold
Downgraded
$194.00
+10.2%
09/14/2026
James Schneider
Goldman Sachs
Buy
Maintained
$230.00
+30.6%
09/11/2026
Darrin Peller
Wolfe Research
Buy
Maintained
$215.00
+22.1%
08/25/2026
Bryan Keane
Citi
Hold
Maintained
$190.00
+7.9%
08/24/2026
James Friedman
Susquehanna
Hold
Maintained
$140.00
-20.5%
07/14/2026
Sean Kennedy
Mizuho Securities
Buy
Maintained
$226.00
+28.3%
06/22/2026
Dan Dolev
Mizuho Securities
Buy
Maintained
$226.00
+28.3%
06/22/2026
Arvind Ramnani
Truist Financial
Hold
Maintained
$150.00
-14.8%
06/22/2026
Daniel Perlin
RBC Capital
Buy
Maintained
$175.00
-0.6%
06/22/2026
David Paige
RBC Capital
Buy
Maintained
$175.00
-0.6%
06/22/2026
Kevin Mcveigh
UBS
Buy
Maintained
$275.00
+56.2%
06/22/2026
David Grossman
Stifel Nicolaus
Buy
Maintained
$225.00
+27.8%
06/21/2026
Maggie Nolan
William Blair
Hold
Downgraded
-
-
06/20/2026
David Koning
Robert W. Baird
Buy
Maintained
$190.00
+7.9%
06/18/2026
Amit Daryanani
Evercore ISI
Buy
Maintained
$180.00
+2.2%
06/18/2026
Meha Pau
Berenberg Bank
Buy
Maintained
$220.00
+24.9%
06/16/2026
Phani Kanumuri
HSBC
Hold
Upgraded
$220.00
+24.9%
03/20/2026
Arun Viswanathan
RBC Capital
Buy
Reiterated
$253.00
+43.7%
03/19/2026
Jim Kelleher
Argus Research
Buy
Reiterated
$335.00
+90.2%
03/20/2026
Next call in 5 days
Thu, Oct 1, 8:00 AM
Fiscal period
Q4 2026
EPS / Est. (USD)
- / $3.18
Revenue / Est. (USD)
- / 18.04B
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Aug 2025
Nov 2025
Feb 2026
May 2026
Revenue
17.60B
18.74B
18.04B
18.72B
Cost of goods sold
11.99B
12.55B
12.58B
12.58B
Cost of revenue
11.99B
12.55B
12.58B
12.58B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.93B
3.02B
2.97B
2.96B
Operating expense
2.93B
3.02B
2.97B
2.96B
Total operating expenses
14.92B
15.56B
15.55B
15.54B
Operating income
2.68B
3.18B
2.49B
3.18B
Other non operating income
59.16M
77.84M
-39.14M
28.30M
EBT including unusual items
2.08B
2.97B
2.46B
3.15B
EBT excluding unusual items
2.69B
3.28B
2.46B
3.15B
Income tax expense
625.43M
725.77M
597.27M
761.94M
Effective tax rate
30.14%
24.46%
24.31%
24.19%
Other operating expenses
-
-
-
-
Net income
1.41B
2.21B
1.83B
2.34B
Net profit margin
8.04%
11.80%
10.12%
12.50%
Earnings per share
3.03
3.94
2.93
3.80
Interest and investment income
105.20M
106.22M
78.54M
75.07M
Interest expense
-66.24M
-65.36M
-63.57M
-70.64M
Net interest expenses
38.95M
40.86M
14.97M
4.42M
Depreciation and amortization charges
-
-
-
-
EBITDA
3.18B
3.48B
2.81B
3.48B
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps